Warren G. Nighan's most recent trade in Angiodynamic Inc was a trade of 4,060 Common Stock done at an average price of $12.3 . Disclosure was reported to the exchange on Jan. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 16 Jan 2025 | 4,060 | 41,817 (0%) | 0% | 12.3 | 49,979 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Purchase of securities on an exchange or from another person at price $ 6.09 per share. | 07 Oct 2024 | 768 | 45,777 (0%) | 0% | 6.1 | 4,677 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Purchase of securities on an exchange or from another person at price $ 6.08 per share. | 07 Oct 2024 | 100 | 45,877 (0%) | 0% | 6.1 | 608 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 277 | 40,998 (0%) | 0% | 7.1 | 1,975 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 251 | 41,275 (0%) | 0% | 7.1 | 1,790 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 19 Jul 2024 | 735 | 41,526 (0%) | 0% | 7.2 | 5,277 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 23,952 | 23,952 | - | - | Performance Right | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 23,507 | 23,507 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 18,733 | 42,261 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 7,550 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 5,677 | 46,675 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 1,666 | 45,009 (0%) | 0% | 7.4 | 12,328 | Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 8,027 | 8,027 | - | - | Non- Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 6,852 | 6,852 | - | - | Performance Right | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 3,426 | 39,619 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 6,452 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 3,233 | 37,112 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.54 per share. | 07 Jul 2022 | 919 | 36,193 (0%) | 0% | 20.5 | 18,876 | Common Stock |